Viewing Study NCT01712061


Ignite Creation Date: 2025-12-24 @ 12:32 PM
Ignite Modification Date: 2025-12-28 @ 9:00 AM
Study NCT ID: NCT01712061
Status: COMPLETED
Last Update Posted: 2015-10-21
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
Sponsor: Pfizer
Organization: